Canada · information only
Methylphenidate shortages
Includes Ritalin, Ritalin SR, Concerta, Biphentin, Foquest, Jornay PM and generics.
Last checked: October 18, 2026. We check once a day.
Next step
Talk to your pharmacist
Your pharmacist can tell you what they have in stock and whether another maker or strength is available. Talk to your prescriber before any change to your medication.
6 reports. Each one covers a single product from one company. Other makers or strengths may still be available.
APO-METHYLPHENIDATE 5MG
Reported shortage- Form
- tablet
- Company
- APOTEX INC
- DIN
- 02273950
- Started
- September 29, 2026
- Expected end
- October 30, 2026 (company estimate)
- Reason given
- Disruption of the manufacture of the drug.
- Report updated
- October 16, 2026
PMS-METHYLPHENIDATE CR 15MG
Reported shortage- Form
- capsule (extended release)
- Company
- PHARMASCIENCE INC
- DIN
- 02536951
- Started
- May 22, 2026
- Expected end
- November 15, 2026 (company estimate)
- Reason given
- Disruption of the manufacture of the drug.
- Report updated
- July 27, 2026
TEVA-METHYLPHENIDATE ER-C 18MG
Reported shortage- Form
- tablet (extended-release)
- Company
- TEVA CANADA LIMITED
- DIN
- 02315068
- Started
- January 30, 2018
- Expected end
- Not given yet
- Reason given
- Disruption of the manufacture of the drug.
- Report updated
- January 21, 2020 (not updated in over a year, so ask your pharmacist whether it still applies)
TEVA-METHYLPHENIDATE ER-C 27MG
Reported shortage- Form
- tablet (extended-release)
- Company
- TEVA CANADA LIMITED
- DIN
- 02315076
- Started
- January 30, 2018
- Expected end
- Not given yet
- Reason given
- Disruption of the manufacture of the drug.
- Report updated
- January 21, 2020 (not updated in over a year, so ask your pharmacist whether it still applies)
TEVA-METHYLPHENIDATE ER-C 36MG
Reported shortage- Form
- tablet (extended-release)
- Company
- TEVA CANADA LIMITED
- DIN
- 02315084
- Started
- January 30, 2018
- Expected end
- Not given yet
- Reason given
- Disruption of the manufacture of the drug.
- Report updated
- January 21, 2020 (not updated in over a year, so ask your pharmacist whether it still applies)
TEVA-METHYLPHENIDATE ER-C 54MG
Reported shortage- Form
- tablet (extended-release)
- Company
- TEVA CANADA LIMITED
- DIN
- 02315092
- Started
- January 30, 2018
- Expected end
- Not given yet
- Reason given
- Disruption of the manufacture of the drug.
- Report updated
- January 21, 2020 (not updated in over a year, so ask your pharmacist whether it still applies)
Resolved in the last two weeks
JORNAY PM 20MG
Resolved- Form
- capsule (delayed- and extended-release)
- Company
- KNIGHT THERAPEUTICS INC.
- DIN
- 02553074
- Started
- August 13, 2026
- Resolved
- October 9, 2026
- Reason given
- Demand increase for the drug.
- Report updated
- October 13, 2026
Information only, not medical advice. This page summarizes shortage reports that drug companies file with Health Canada on Health Product Shortages Canada. A reported shortage does not always mean your pharmacy is out. Other makers or strengths may be available, and the end dates companies give are estimates that often change. Do not stop, change or ration a medication based on this page. Talk to your pharmacist about availability, and talk to your prescriber before any change to your treatment.
Data last checked: October 18, 2026. Source: Health Product Shortages Canada, Government of Canada. After the Diagnosis is not affiliated with Health Canada.